OPTINOSE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.08 USD | +8.22% |
|
-4.42% | -16.28% |
| 05-20 | OptiNose, Inc. announced that it has received $4.68 million in funding | CI |
| 05-14 | Transcript : OptiNose, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Chart calendar OptiNose, Inc.
8bd55328a4898a8835.0TA1HhzLnqlNXbP3oS8xhnPruBii7GUez5aa8tZJGo8.l297LUSdzsN4FOu69x8I6kPf03z2lVFBrMD0tO9kfuaiCGNQW4CtzHs26g~422f94270125294d53f3ca6deb074686
Upcoming events on OptiNose, Inc.
Past events on OptiNose, Inc.
| 06/06/2024 13:30 | Annual General Meeting |
| 20/05/2024 16:30 | H.C. Wainwright BioConnect Investor Conference |
| 14/05/2024 15:00 | Q1 2024 Earnings Call |
| 14/05/2024 12:00 | Q1 2024 Earnings Release |
| 25/04/2024 15:00 | Business Update Call |
| 10/04/2024 19:15 | Needham Healthcare Conference |
| 07/03/2024 13:00 | Q4 2023 Earnings Call |
| 07/03/2024 12:00 | Q4 2023 Earnings Release |
| 29/11/2023 20:30 | Piper Sandler Healthcare Conference |
| 09/11/2023 13:00 | Q3 2023 Earnings Call |
| 09/11/2023 12:00 | Q3 2023 Earnings Release |
| 27/09/2023 21:45 | Cantor Global Healthcare Conference |
| 10/08/2023 13:00 | Q2 2023 Earnings Call |
| 10/08/2023 12:00 | Q2 2023 Earnings Release |
| 09/06/2023 15:00 | Jefferies Global Healthcare Conference |
| 08/06/2023 13:30 | Annual General Meeting |
| 11/05/2023 13:00 | Q1 2023 Earnings Call |
| 11/05/2023 12:00 | Q1 2023 Earnings Release |
| 17/04/2023 20:45 | Needham Healthcare Conference |
| 07/03/2023 13:00 | Q4 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 34,6 35,2 -1.52% | 49,1 50,8 -3.24% | 74,7 73,9 1.02% | 76,3 76,1 0.24% | 71,0 70,3 0.92% | 92,2 |
|
EBITDA Million USD | Released Forecast Spread | -84,6 -86,7 2.41% | -85,8 -78,1 -9.81% | -65,8 -59,9 -9.8% | -55,4 -52,7 -5.06% | -22,3 -19,6 -13.74% | -5,42 |
|
EBIT Million USD | Released Forecast Spread | -95,6 -97,3 1.71% | -87,2 -86,4 -0.99% | -66,5 -68,1 2.45% | -55,9 -58,8 4.94% | -22,7 -26,2 13.21% | -12,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -110 -111 1.24% | -99,8 -98,3 -1.49% | -82,3 -83,6 1.51% | -74,8 -72,2 -3.65% | -35,5 -36,1 1.7% | -32,4 |
|
Net income Million USD | Released Forecast Spread | -110 -111 1.24% | -99,8 -98,3 -1.49% | -82,3 -83,6 1.53% | -74,8 -72,2 -3.65% | -35,5 -36,1 1.7% | -32,4 |
|
EPS USD | Released Forecast Spread | -2,63 -2,66 1.22% | -2,07 -2,07 0.12% | -1,45 -1,46 0.96% | -0,87 -0,86 -1.46% | -0,32 -0,32 1.03% | -0,26 |
| Announcement Date | 05/03/20 | 03/03/21 | 08/03/22 | 07/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 14,8 16,7 -11.66% | 20,6 21,5 -4.27% | 20,1 23,4 -14.2% | 20,9 20,7 0.81% | 11,8 10,2 16.14% | 19,5 17,0 14.44% | 19,8 18,5 7.44% | 19,9 19,2 3.46% | 14,9 13,7 8.88% | 21,1 | 24,1 | 32,6 | 24,2 | 33,4 |
|
EBITDA Million USD | Released Forecast Spread | -19,3 -17,0 -13.67% | -8,22 -5,64 -45.71% | -2,10 | -0,63 | 3,44 | |||||||||
|
EBIT Million USD | Released Forecast Spread | -21,4 -18,5 -15.81% | -15,3 -16,3 5.71% | -10,8 -11,8 8.22% | -8,36 -11,2 25.49% | -14,4 -13,5 -6.43% | -4,17 -7,00 40.4% | -1,69 -6,15 72.46% | -2,51 -6,05 58.48% | -8,08 -8,23 1.88% | -5,44 | -2,56 | 3,54 | -2,90 | 1,00 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,3 -22,1 -14.43% | -19,4 -20,1 3.5% | -15,0 -15,7 4.55% | -15,1 -15,5 2.29% | -18,8 -17,7 -6.48% | 2,63 -11,8 122.25% | -9,29 -10,6 12.32% | -9,97 -10,6 5.97% | -14,1 -12,8 -9.89% | -10,2 | -7,32 | -1,24 | -7,70 | -3,80 |
|
Net income Million USD | Released Forecast Spread | -25,3 -22,1 -14.43% | -19,4 -20,1 3.5% | -15,0 -15,7 4.55% | -15,1 -15,5 2.29% | -18,8 -17,7 -6.48% | 2,57 -11,8 121.81% | -9,29 -10,6 12.32% | -9,97 -10,6 5.97% | -14,1 -12,8 -9.89% | -10,2 | -7,32 | -1,24 | -7,70 | -3,80 |
|
EPS USD | Released Forecast Spread | -0,31 -0,27 -14.81% | -0,23 -0,24 5.15% | -0,18 -0,18 2.17% | -0,17 -0,18 2.86% | -0,17 -0,14 -21.43% | 0,02 -0,11 118.18% | -0,08 -0,09 14.28% | -0,09 -0,09 3.57% | -0,12 -0,11 -11.63% | -0,08 | -0,06 | -0,01 | -0,05 | -0,03 |
| Announcement Date | 12/05/22 | 11/08/22 | 10/11/22 | 07/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 07/03/24 | 14/05/24 | - | - | - | - | - |
More events
Past sector events for OptiNose, Inc.
| 21/06/2024 16:28 | DEVA HOLDING: Q1 2024 Earnings Release |
| 13/06/2024 22:21 | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
| 11/06/2024 06:30 | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
| 07/06/2024 11:33 | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
| 07/06/2024 10:17 | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
| 30/05/2024 13:08 | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 30/05/2024 12:00 | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 30/05/2024 07:24 | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 13:00 | FDC LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 10:26 | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OPTN Stock
- Calendar OptiNose, Inc.
